Orchid Pharma informs about transcript of investor call

22 Feb 2023 Evaluate

In continuation of earlier announcements dated February 14, 2023 and February 17, 2023, Orchid Pharma has informed that the Transcript of Investors Call/Earning Call held on Friday, February 17, 2023 on the Un-Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine Months ended December 31, 2022 is enclosed. Further, pursuant to Regulation 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the aforesaid transcript is available on the Company's website: www.orchidpharma.com.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

1071.30 -19.25 (-1.77%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.